ES2058896T3 - Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos. - Google Patents

Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos.

Info

Publication number
ES2058896T3
ES2058896T3 ES90904600T ES90904600T ES2058896T3 ES 2058896 T3 ES2058896 T3 ES 2058896T3 ES 90904600 T ES90904600 T ES 90904600T ES 90904600 T ES90904600 T ES 90904600T ES 2058896 T3 ES2058896 T3 ES 2058896T3
Authority
ES
Spain
Prior art keywords
group
trans
preparation
link
leucotrene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90904600T
Other languages
English (en)
Spanish (es)
Inventor
Josef Heindl
Werner Skuballa
Bernd Buchmann
Wolfgang Frohlich
Roland Ekerdt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2058896T3 publication Critical patent/ES2058896T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES90904600T 1989-03-17 1990-03-16 Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos. Expired - Lifetime ES2058896T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3909326A DE3909326A1 (de) 1989-03-17 1989-03-17 Neue leukotrien-b4-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES2058896T3 true ES2058896T3 (es) 1994-11-01

Family

ID=6376895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90904600T Expired - Lifetime ES2058896T3 (es) 1989-03-17 1990-03-16 Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos.

Country Status (8)

Country Link
US (1) US5183925A (fr)
EP (1) EP0416069B1 (fr)
JP (1) JPH03505220A (fr)
AT (1) ATE92031T1 (fr)
DE (2) DE3909326A1 (fr)
DK (1) DK0416069T3 (fr)
ES (1) ES2058896T3 (fr)
WO (1) WO1990011272A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120698A1 (de) * 1991-06-22 1992-12-24 Gruenenthal Gmbh Substituierte phenoxyalkanole und deren ester, diese verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109225B1 (fr) * 1982-11-11 1985-08-28 Beecham Group Plc Analogues de l'acide arachidonique, leurs procédés de préparation et leur application en thérapeutique
ES2052639T3 (es) * 1987-06-26 1994-07-16 Searle & Co Analogos de fenilen-, furil- y tienil-leucotrieno b4.

Also Published As

Publication number Publication date
WO1990011272A1 (fr) 1990-10-04
US5183925A (en) 1993-02-02
DE59002088D1 (de) 1993-09-02
DE3909326A1 (de) 1990-09-20
ATE92031T1 (de) 1993-08-15
DK0416069T3 (da) 1993-12-20
EP0416069B1 (fr) 1993-07-28
JPH03505220A (ja) 1991-11-14
EP0416069A1 (fr) 1991-03-13

Similar Documents

Publication Publication Date Title
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2185772T3 (es) Derivados de 1,3-propano-diol como compuestos bioactivos.
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2031841T3 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.
ES2028857T3 (es) Procedimiento para la preparacion de derivados de amino-tiazol y amino-oxazol.
ES2090065T3 (es) Esteres de acido fosforico, procedimiento para su fabricacion y su utilizacion como agente dispersante.
ES2046196T3 (es) Derivados de azacicloalcanos, promotores de absorcion que contienen los derivados como ingrediente eficaz y preparaciones externas que contienen los promotores de absorcion.
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
ATE67995T1 (de) Flavonkarbonsaeure-derivate.
AR241514A1 (es) Un proceso para producir un preparado farmaceutico estable que contiene nicorandil.
ES2159922T3 (es) Nuevos derivados de bencimidazol, de benzoxazol y de benzotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2045052T3 (es) Antagonistas de leucotrienos ltd4 y ltb4.
ES2038359T3 (es) Procedimiento para la obtencion de formulaciones inyectables intramusculares de inhibidores de girasa.
AR241017A2 (es) "procedimiento para la preparacion de fenil-silfonil-oxi-bencimidazol-carbamatos sustituidos."
ES2058896T3 (es) Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos.
ES2115220T3 (es) Nuevo uso de compuestos bis-heterociclicos como agentes antiinflamatorios y composiciones farmaceuticas de los mismos.
ES2069281T3 (es) Derivado de fenantreno.
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
ES2140765T3 (es) Guanididas sustituidas del acido cinamico, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico cardiovascular, asi como medicamento que las contiene.
ES2090066T3 (es) Preparaciones externas que contienen agua y propionato de deprodona.
ES2139965T3 (es) Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2065475T3 (es) Nuevos derivados de leucotrieno-b4, procedimiento para su produccion y su empleo como medicamentos.
AR240815A2 (es) Procedimiento para preparar derivados de los acidos benzofuran-5-il y benzotiofen-5-il acetico y propionico
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 416069

Country of ref document: ES